Analytical Data
-
Gene name
SYCN
- Application
-
Alternative Names
SYL; INSSA1; Insulin Synthesis Associated 1
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q0VAF6
-
Expression Region
Cys38~Ser134
-
Molecular Weight
44kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of SYCN (Synaptotagmin-Ca2+ binding protein) recombinant proteins has garnered significant attention in the field of molecular biology and neuroscience due to its critical role in synaptic transmission and neurotransmitter release. SYCN is a member of the synaptotagmin family, which is characterized by its ability to bind calcium ions and facilitate the fusion of synaptic vesicles with the presynaptic membrane. This process is essential for effective communication between neurons and plays a fundamental role in various neurological processes, including learning and memory. Understanding the structure and function of SYCN at a molecular level can provide insights into its mechanisms of action and potential dysregulation in neurological disorders. Research involving SYCN recombinant proteins aims to explore their binding interactions, calcium sensitivity, and regulatory mechanisms, thereby elucidating their contribution to synaptic physiology. Additionally, recombinant protein technology allows for the production of large quantities of SYCN, enabling detailed biochemical and biophysical analyses that can further our understanding of synaptic dynamics. As such, the investigation of SYCN recombinant proteins not only advances our knowledge of synaptic function but also holds promise for developing therapeutic strategies for disorders associated with synaptic dysfunction, such as epilepsy, anxiety, and schizophrenia. Overall, the study of SYCN and its recombinant variants is vital for uncovering the complexities of neural communication and the underlying mechanisms of various neurological diseases.
